Try our Advanced Search for more refined results

IN RE: AVANDIA MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION

Track this case

Case Number:

2:07-md-01871

Court:

Pennsylvania Eastern

Nature of Suit:

P.I.: Personal Inj. Prod. Liability

Multi Party Litigation:

Multi-district Litigation

Judge:

CYNTHIA M. RUFE

Firms

Companies

Sectors & Industries:

November 08, 2011
GSK Prodded Toward Mediation In Avandia MDL

Less than a week after GlaxoSmithKline PLC paid $3 billion to settle U.S. government probes into, among other practices, its marketing of Avandia, a Pennsylvania federal judge on Monday pushed the drugmaker toward mediation with plaintiffs in multidistrict litigation over the controversial diabetes drug.
October 28, 2011
County Can't Pursue Own Avandia False Ad Claims: Judge

A Pennsylvania federal judge ruled Wednesday that a California county can't personally pursue a false advertising suit in multidistrict litigation over GlaxoSmithKline PLC's alleged concealment of the risks of diabetes medication Avandia, but that it can assert the claims on behalf of state residents.
January 05, 2011
GSK Loses Bid To Bar Testimony On Avandia Risks

GlaxoSmithKline PLC has lost its bid to block three doctors from testifying about the alleged health risks of Avandia in a multidistrict litigation alleging the company concealed the diabetes medication's potential to cause heart attack and stroke in some patients.

← Previous
1
2
3
Next →